Membrane transporters as mediators of synaptic dopamine dynamics: implications for disease.
Identifieur interne : 000055 ( PubMed/Checkpoint ); précédent : 000054; suivant : 000056Membrane transporters as mediators of synaptic dopamine dynamics: implications for disease.
Auteurs : Kelly M. Lohr [États-Unis] ; Shababa T. Masoud [Canada] ; Ali Salahpour [Canada] ; Gary W. Miller [États-Unis]Source :
- The European journal of neuroscience [ 1460-9568 ] ; 2017.
Abstract
Dopamine was first identified as a neurotransmitter localized to the midbrain over 50 years ago. The dopamine transporter (DAT; SLC6A3) and the vesicular monoamine transporter 2 (VMAT2; SLC18A2) are regulators of dopamine homeostasis in the presynaptic neuron. DAT transports dopamine from the extracellular space into the cytosol of the presynaptic terminal. VMAT2 then packages this cytosolic dopamine into vesicular compartments for subsequent release upon neurotransmission. Thus, DAT and VMAT2 act in concert to move the transmitter efficiently throughout the neuron. Accumulation of dopamine in the neuronal cytosol can trigger oxidative stress and neurotoxicity, suggesting that the proper compartmentalization of dopamine is critical for neuron function and risk of disease. For decades, studies have examined the effects of reduced transporter function in mice (e.g. DAT-KO, VMAT2-KO, VMAT2-deficient). However, we have only recently been able to assess the effects of elevated transporter expression using BAC transgenic methods (DAT-tg, VMAT2-HI mice). Complemented with in vitro work and neurochemical techniques to assess dopamine compartmentalization, a new focus on the importance of transporter proteins as both models of human disease and potential drug targets has emerged. Here, we review the importance of DAT and VMAT2 function in the delicate balance of neuronal dopamine.
DOI: 10.1111/ejn.13357
PubMed: 27520881
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:27520881Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Membrane transporters as mediators of synaptic dopamine dynamics: implications for disease.</title><author><name sortKey="Lohr, Kelly M" sort="Lohr, Kelly M" uniqKey="Lohr K" first="Kelly M" last="Lohr">Kelly M. Lohr</name><affiliation wicri:level="1"><nlm:affiliation>Department of Environmental Health, Rollins School of Public Health, Emory University, 1518 Clifton Road, Atlanta, GA, 30322, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Environmental Health, Rollins School of Public Health, Emory University, 1518 Clifton Road, Atlanta, GA, 30322</wicri:regionArea><wicri:noRegion>30322</wicri:noRegion></affiliation></author><author><name sortKey="Masoud, Shababa T" sort="Masoud, Shababa T" uniqKey="Masoud S" first="Shababa T" last="Masoud">Shababa T. Masoud</name><affiliation wicri:level="4"><nlm:affiliation>Department of Pharmacology and Toxicology, University of Toronto, ON, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Department of Pharmacology and Toxicology, University of Toronto, ON</wicri:regionArea><orgName type="university">Université de Toronto</orgName><placeName><settlement type="city">Toronto</settlement><region type="state">Ontario</region></placeName></affiliation></author><author><name sortKey="Salahpour, Ali" sort="Salahpour, Ali" uniqKey="Salahpour A" first="Ali" last="Salahpour">Ali Salahpour</name><affiliation wicri:level="4"><nlm:affiliation>Department of Pharmacology and Toxicology, University of Toronto, ON, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Department of Pharmacology and Toxicology, University of Toronto, ON</wicri:regionArea><orgName type="university">Université de Toronto</orgName><placeName><settlement type="city">Toronto</settlement><region type="state">Ontario</region></placeName></affiliation></author><author><name sortKey="Miller, Gary W" sort="Miller, Gary W" uniqKey="Miller G" first="Gary W" last="Miller">Gary W. Miller</name><affiliation wicri:level="1"><nlm:affiliation>Department of Environmental Health, Rollins School of Public Health, Emory University, 1518 Clifton Road, Atlanta, GA, 30322, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Environmental Health, Rollins School of Public Health, Emory University, 1518 Clifton Road, Atlanta, GA, 30322</wicri:regionArea><wicri:noRegion>30322</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2017">2017</date><idno type="RBID">pubmed:27520881</idno><idno type="pmid">27520881</idno><idno type="doi">10.1111/ejn.13357</idno><idno type="wicri:Area/PubMed/Corpus">000089</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000089</idno><idno type="wicri:Area/PubMed/Curation">000089</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000089</idno><idno type="wicri:Area/PubMed/Checkpoint">000089</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000089</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Membrane transporters as mediators of synaptic dopamine dynamics: implications for disease.</title><author><name sortKey="Lohr, Kelly M" sort="Lohr, Kelly M" uniqKey="Lohr K" first="Kelly M" last="Lohr">Kelly M. Lohr</name><affiliation wicri:level="1"><nlm:affiliation>Department of Environmental Health, Rollins School of Public Health, Emory University, 1518 Clifton Road, Atlanta, GA, 30322, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Environmental Health, Rollins School of Public Health, Emory University, 1518 Clifton Road, Atlanta, GA, 30322</wicri:regionArea><wicri:noRegion>30322</wicri:noRegion></affiliation></author><author><name sortKey="Masoud, Shababa T" sort="Masoud, Shababa T" uniqKey="Masoud S" first="Shababa T" last="Masoud">Shababa T. Masoud</name><affiliation wicri:level="4"><nlm:affiliation>Department of Pharmacology and Toxicology, University of Toronto, ON, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Department of Pharmacology and Toxicology, University of Toronto, ON</wicri:regionArea><orgName type="university">Université de Toronto</orgName><placeName><settlement type="city">Toronto</settlement><region type="state">Ontario</region></placeName></affiliation></author><author><name sortKey="Salahpour, Ali" sort="Salahpour, Ali" uniqKey="Salahpour A" first="Ali" last="Salahpour">Ali Salahpour</name><affiliation wicri:level="4"><nlm:affiliation>Department of Pharmacology and Toxicology, University of Toronto, ON, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Department of Pharmacology and Toxicology, University of Toronto, ON</wicri:regionArea><orgName type="university">Université de Toronto</orgName><placeName><settlement type="city">Toronto</settlement><region type="state">Ontario</region></placeName></affiliation></author><author><name sortKey="Miller, Gary W" sort="Miller, Gary W" uniqKey="Miller G" first="Gary W" last="Miller">Gary W. Miller</name><affiliation wicri:level="1"><nlm:affiliation>Department of Environmental Health, Rollins School of Public Health, Emory University, 1518 Clifton Road, Atlanta, GA, 30322, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Environmental Health, Rollins School of Public Health, Emory University, 1518 Clifton Road, Atlanta, GA, 30322</wicri:regionArea><wicri:noRegion>30322</wicri:noRegion></affiliation></author></analytic><series><title level="j">The European journal of neuroscience</title><idno type="eISSN">1460-9568</idno><imprint><date when="2017" type="published">2017</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Dopamine was first identified as a neurotransmitter localized to the midbrain over 50 years ago. The dopamine transporter (DAT; SLC6A3) and the vesicular monoamine transporter 2 (VMAT2; SLC18A2) are regulators of dopamine homeostasis in the presynaptic neuron. DAT transports dopamine from the extracellular space into the cytosol of the presynaptic terminal. VMAT2 then packages this cytosolic dopamine into vesicular compartments for subsequent release upon neurotransmission. Thus, DAT and VMAT2 act in concert to move the transmitter efficiently throughout the neuron. Accumulation of dopamine in the neuronal cytosol can trigger oxidative stress and neurotoxicity, suggesting that the proper compartmentalization of dopamine is critical for neuron function and risk of disease. For decades, studies have examined the effects of reduced transporter function in mice (e.g. DAT-KO, VMAT2-KO, VMAT2-deficient). However, we have only recently been able to assess the effects of elevated transporter expression using BAC transgenic methods (DAT-tg, VMAT2-HI mice). Complemented with in vitro work and neurochemical techniques to assess dopamine compartmentalization, a new focus on the importance of transporter proteins as both models of human disease and potential drug targets has emerged. Here, we review the importance of DAT and VMAT2 function in the delicate balance of neuronal dopamine.</div></front></TEI><pubmed><MedlineCitation Status="In-Process" Owner="NLM"><PMID Version="1">27520881</PMID><DateCreated><Year>2016</Year><Month>09</Month><Day>03</Day></DateCreated><DateRevised><Year>2017</Year><Month>02</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1460-9568</ISSN><JournalIssue CitedMedium="Internet"><Volume>45</Volume><Issue>1</Issue><PubDate><Year>2017</Year><Month>Jan</Month></PubDate></JournalIssue><Title>The European journal of neuroscience</Title><ISOAbbreviation>Eur. J. Neurosci.</ISOAbbreviation></Journal><ArticleTitle>Membrane transporters as mediators of synaptic dopamine dynamics: implications for disease.</ArticleTitle><Pagination><MedlinePgn>20-33</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/ejn.13357</ELocationID><Abstract><AbstractText>Dopamine was first identified as a neurotransmitter localized to the midbrain over 50 years ago. The dopamine transporter (DAT; SLC6A3) and the vesicular monoamine transporter 2 (VMAT2; SLC18A2) are regulators of dopamine homeostasis in the presynaptic neuron. DAT transports dopamine from the extracellular space into the cytosol of the presynaptic terminal. VMAT2 then packages this cytosolic dopamine into vesicular compartments for subsequent release upon neurotransmission. Thus, DAT and VMAT2 act in concert to move the transmitter efficiently throughout the neuron. Accumulation of dopamine in the neuronal cytosol can trigger oxidative stress and neurotoxicity, suggesting that the proper compartmentalization of dopamine is critical for neuron function and risk of disease. For decades, studies have examined the effects of reduced transporter function in mice (e.g. DAT-KO, VMAT2-KO, VMAT2-deficient). However, we have only recently been able to assess the effects of elevated transporter expression using BAC transgenic methods (DAT-tg, VMAT2-HI mice). Complemented with in vitro work and neurochemical techniques to assess dopamine compartmentalization, a new focus on the importance of transporter proteins as both models of human disease and potential drug targets has emerged. Here, we review the importance of DAT and VMAT2 function in the delicate balance of neuronal dopamine.</AbstractText><CopyrightInformation>© 2016 Federation of European Neuroscience Societies and John Wiley & Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lohr</LastName><ForeName>Kelly M</ForeName><Initials>KM</Initials><AffiliationInfo><Affiliation>Department of Environmental Health, Rollins School of Public Health, Emory University, 1518 Clifton Road, Atlanta, GA, 30322, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Masoud</LastName><ForeName>Shababa T</ForeName><Initials>ST</Initials><AffiliationInfo><Affiliation>Department of Pharmacology and Toxicology, University of Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salahpour</LastName><ForeName>Ali</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Pharmacology and Toxicology, University of Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miller</LastName><ForeName>Gary W</ForeName><Initials>GW</Initials><AffiliationInfo><Affiliation>Department of Environmental Health, Rollins School of Public Health, Emory University, 1518 Clifton Road, Atlanta, GA, 30322, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Neurodegenerative Diseases, Emory University, Atlanta, GA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pharmacology, Emory University, Atlanta, GA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Emory University, Atlanta, GA, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P01 ES016731</GrantID><Acronym>ES</Acronym><Agency>NIEHS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>F31 NS084739</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 ES023839</GrantID><Acronym>ES</Acronym><Agency>NIEHS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 NS096050</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 ES019776</GrantID><Acronym>ES</Acronym><Agency>NIEHS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>09</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>France</Country><MedlineTA>Eur J Neurosci</MedlineTA><NlmUniqueID>8918110</NlmUniqueID><ISSNLinking>0953-816X</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Mol Psychiatry. 2000 May;5(3):275-82</RefSource><PMID Version="1">10889530</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurosci. 1999 Feb 15;19(4):1484-91</RefSource><PMID Version="1">9952424</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neuropsychopharmacology. 2007 Dec;32(12):2465-78</RefSource><PMID Version="1">17375139</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Psychiatry. 2006 Jan;11(1):99-113</RefSource><PMID Version="1">16189511</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO Mol Med. 2009 May;1(2):99-111</RefSource><PMID Version="1">20049710</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biol Psychiatry. 2001 Jan 15;49(2):110-6</RefSource><PMID Version="1">11164757</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Toxicol Ind Health. 2010 Mar;26(2):121-8</RefSource><PMID Version="1">20207656</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Drug Abuse Rev. 2009 May;2(2):195-213</RefSource><PMID Version="1">19630749</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Pharmacol Rev. 1966 Jun;18(2):925-64</RefSource><PMID Version="1">5328389</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neurosci Lett. 1987 Apr 10;75(3):323-8</RefSource><PMID Version="1">3495754</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Chem Res Toxicol. 2009 Jul;22(7):1256-63</RefSource><PMID Version="1">19537779</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biol Psychiatry. 2011 Jun 15;69(12 ):e145-57</RefSource><PMID Version="1">21550021</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurosci. 2011 Feb 9;31(6):2225-37</RefSource><PMID Version="1">21307259</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Neurobiol. 2009 Apr;39(2):149-70</RefSource><PMID Version="1">19259829</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2001 Nov 9;294(5545):1346-9</RefSource><PMID Version="1">11701929</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochem Pharmacol. 2002 Jan 15;63(2):89-98</RefSource><PMID Version="1">11841781</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochem Pharmacol. 2008 Jan 1;75(1):196-217</RefSource><PMID Version="1">17825265</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neuron. 1997 Dec;19(6):1285-96</RefSource><PMID Version="1">9427251</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neurotox Res. 2007 Apr;11(3-4):151-67</RefSource><PMID Version="1">17449457</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Physiol Rev. 1995 Apr;75(2):369-92</RefSource><PMID Version="1">7724667</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trends Neurosci. 2008 Jun;31(6):303-8</RefSource><PMID Version="1">18471904</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 1999 Jan 15;283(5400):397-401</RefSource><PMID Version="1">9888856</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Transl Psychiatry. 2014 Oct 14;4:e464</RefSource><PMID Version="1">25313507</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Toxicol Sci. 2016 Sep;153(1):79-88</RefSource><PMID Version="1">27287315</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Psychiatry. 1997 Jul;2(4):311-3</RefSource><PMID Version="1">9246671</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Acta Neurol Scand Suppl. 1972;51:11-42</RefSource><PMID Version="1">4351191</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Protein Sci. 2004 Jul;13(7):1832-40</RefSource><PMID Version="1">15215526</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Med Genet. 2002 Dec 8;114(8):975-9</RefSource><PMID Version="1">12457396</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Head Trauma Rehabil. 2016 Jan 29;:null</RefSource><PMID Version="1">26828714</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 1962 Jan 12;135(3498):107-8</RefSource><PMID Version="1">14456354</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neuropsychopharmacology. 2006 Oct;31(10):2132-9</RefSource><PMID Version="1">16407898</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Mutat. 2013 Sep;34(9):1200-7</RefSource><PMID Version="1">23804563</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Behav Brain Sci. 2005 Jun;28(3):397-419; discussion 419-68</RefSource><PMID Version="1">16209748</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2007 Jul 3;104(27):11441-6</RefSource><PMID Version="1">17563363</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Annu Rev Pharmacol Toxicol. 2003;43:261-84</RefSource><PMID Version="1">12359863</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Pharmacol Exp Ther. 2010 Feb;332(2):612-21</RefSource><PMID Version="1">19855096</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Neurosci. 1999 Jul;2(7):649-55</RefSource><PMID Version="1">10404198</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1997 Sep 2;94(18):9938-43</RefSource><PMID Version="1">9275230</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 1994 Mar 11;269(10):7231-7</RefSource><PMID Version="1">8125935</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neurobiol Dis. 2012 Sep;47(3):367-77</RefSource><PMID Version="1">22659302</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Invest. 2009 Jun;119(6):1595-603</RefSource><PMID Version="1">19478460</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 1987 Sep 4;237(4819):1219-23</RefSource><PMID Version="1">2820058</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur J Neurosci. 1999 Oct;11(10):3499-511</RefSource><PMID Version="1">10564358</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet Neurol. 2011 Jan;10 (1):54-62</RefSource><PMID Version="1">21112253</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO J. 1984 Dec 20;3(13):3333-7</RefSource><PMID Version="1">6151900</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neurotoxicology. 2012 Oct;33(5):1298-304</RefSource><PMID Version="1">22906799</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurosci. 2011 May 18;31(20):7264-74</RefSource><PMID Version="1">21593311</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur J Pharmacol. 1984 Jul 20;102(3-4):425-30</RefSource><PMID Version="1">6489435</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neurobiol Dis. 2011 Sep;43(3):651-62</RefSource><PMID Version="1">21645620</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 1954 Dec 16;251(25):1006-8</RefSource><PMID Version="1">13214379</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trends Neurosci. 2007 May;30(5):244-50</RefSource><PMID Version="1">17418429</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neuron. 2000 Oct;28(1):205-20</RefSource><PMID Version="1">11086995</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2013 Feb 7;368(6):543-50</RefSource><PMID Version="1">23363473</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neuron. 2005 Feb 17;45(4):489-96</RefSource><PMID Version="1">15721235</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2010 Jan 15;285(3):1957-66</RefSource><PMID Version="1">19903816</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neural Transm (Vienna). 2013 Aug;120(8):1161-9</RefSource><PMID Version="1">23504072</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biol Psychiatry. 2003 Oct 15;54(8):800-5</RefSource><PMID Version="1">14550679</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neuroscience. 2014 Dec 12;282:248-57</RefSource><PMID Version="1">25445194</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Tissue Res. 2004 Oct;318(1):215-24</RefSource><PMID Version="1">15503155</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2014 Jul 8;111(27):9977-82</RefSource><PMID Version="1">24979780</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1998 Mar 31;95(7):4029-34</RefSource><PMID Version="1">9520487</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Hum Genet. 1995 Apr;56(4):993-8</RefSource><PMID Version="1">7717410</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochem Biophys Res Commun. 1990 Nov 30;173(1):443-8</RefSource><PMID Version="1">1979489</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neuropharmacology. 2014 Jan;76 Pt A:97-105</RefSource><PMID Version="1">24025942</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Psychiatry. 2000 May;5(3):283-92</RefSource><PMID Version="1">10889531</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Environ Health Perspect. 2009 Jun;117(6):964-9</RefSource><PMID Version="1">19590691</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cold Spring Harb Perspect Med. 2012 Sep 01;2(9):a009415</RefSource><PMID Version="1">22951446</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trends Pharmacol Sci. 2006 Jul;27(7):375-83</RefSource><PMID Version="1">16762425</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 1996 Feb 15;379(6566):606-12</RefSource><PMID Version="1">8628395</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Pharmacol. 2008 Mar;73(3):813-23</RefSource><PMID Version="1">17978168</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2012;7(2):e31522</RefSource><PMID Version="1">22384032</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Pharmacol Exp Ther. 2000 May;293(2):329-35</RefSource><PMID Version="1">10772999</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Opin Neurobiol. 1998 Jun;8(3):405-12</RefSource><PMID Version="1">9687352</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>JAMA. 2009 Mar 18;301(11):1148-54</RefSource><PMID Version="1">19293415</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int Rev Neurobiol. 1993;35:279-390</RefSource><PMID Version="1">8463062</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Neurosci. 2003 Jan;4(1):13-25</RefSource><PMID Version="1">12511858</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurosci. 2007 Sep 26;27(39):10520-9</RefSource><PMID Version="1">17898223</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Klin Wochenschr. 1960 Dec 15;38:1236-9</RefSource><PMID Version="1">13726012</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Psychiatry Res. 2002 Nov 15;112(3):251-6</RefSource><PMID Version="1">12450634</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Brain. 2014 Apr;137(Pt 4):1107-19</RefSource><PMID Version="1">24613933</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1992 Oct 1;89(19):9074-8</RefSource><PMID Version="1">1409604</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurosci. 1995 May;15(5 Pt 2):4102-8</RefSource><PMID Version="1">7751968</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur J Epidemiol. 2011 Jun;26 Suppl 1:S1-58</RefSource><PMID Version="1">21626386</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur Neuropsychopharmacol. 2007 Jul;17(8):523-6</RefSource><PMID Version="1">17344033</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neurotoxicology. 2014 Sep;44:279-87</RefSource><PMID Version="1">25092410</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Behav Brain Res. 2002 Mar 10;130(1-2):203-7</RefSource><PMID Version="1">11864736</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Drug Alcohol Depend. 2015 Feb 1;147:1-19</RefSource><PMID Version="1">25548026</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neuropsychopharmacology. 2004 Feb;29(2):221-8</RefSource><PMID Version="1">14603268</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Psychiatry. 2013 Dec;18(12):1315-23</RefSource><PMID Version="1">23979605</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur Neuropsychopharmacol. 2005 Mar;15(2):159-62</RefSource><PMID Version="1">15695060</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2008 Mar 18;105(11):4405-10</RefSource><PMID Version="1">18347339</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neuropharmacology. 1987 Sep;26(9):1431-40</RefSource><PMID Version="1">3670563</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2011;6(10):e25790</RefSource><PMID Version="1">22043293</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann N Y Acad Sci. 2011 Jan;1216:86-98</RefSource><PMID Version="1">21272013</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 1988 Oct 25;263(30):15423-8</RefSource><PMID Version="1">2902091</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Toxicol Sci. 2004 Aug;80(2):288-95</RefSource><PMID Version="1">15115888</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trends Pharmacol Sci. 1999 Oct;20(10):424-9</RefSource><PMID Version="1">10498956</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>JAMA. 1999 Jan 27;281(4):341-6</RefSource><PMID Version="1">9929087</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurochem. 2008 Apr;105(1):78-90</RefSource><PMID Version="1">17988241</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurosci. 2007 Jul 25;27(30):8138-48</RefSource><PMID Version="1">17652604</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neurobiol Dis. 2015 Feb;74:66-75</RefSource><PMID Version="1">25447236</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Psychiatry. 2003 Apr;8(4):393-6</RefSource><PMID Version="1">12740596</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Exp Neurol. 1999 Feb;155(2):268-73</RefSource><PMID Version="1">10072302</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochemistry. 1990 Jan 23;29(3):603-8</RefSource><PMID Version="1">2140052</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Handb Exp Pharmacol. 2008;(184):77-106</RefSource><PMID Version="1">18064412</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Psychiatry. 2000 Oct;157(10 ):1619-28</RefSource><PMID Version="1">11007716</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neurobiol Aging. 2013 Jun;34(6):1712.e9-13</RefSource><PMID Version="1">23369548</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neuropsychopharmacology. 2014 Jul;39(8):1872-9</RefSource><PMID Version="1">24525708</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Exp Neurol. 2013 Mar;241:138-47</RefSource><PMID Version="1">23287494</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurosci. 2009 Jun 24;29(25):8103-13</RefSource><PMID Version="1">19553450</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Neurol. 1998 May;43(5):555-60</RefSource><PMID Version="1">9585349</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur J Neurol. 2011 May;18(5):703-10</RefSource><PMID Version="1">21073636</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mov Disord. 1997 Sep;12(5):629-33</RefSource><PMID Version="1">9380041</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2002 Oct 11;277(41):38884-94</RefSource><PMID Version="1">12145295</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Parkinsons Dis. 2011 Feb 21;2011:124165</RefSource><PMID Version="1">21403896</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Biol. 2005 Aug;3(8):e271</RefSource><PMID Version="1">16050778</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurochem. 1997 Sep;69(3):1322-5</RefSource><PMID Version="1">9282960</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurochem. 2008 Sep;106(5):2205-17</RefSource><PMID Version="1">18643795</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Exp Neurol. 1999 Mar;156(1):138-48</RefSource><PMID Version="1">10192785</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Pharmacol Exp Ther. 2016 Apr;357(1):24-35</RefSource><PMID Version="1">26813929</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 1992 Aug 21;70(4):539-51</RefSource><PMID Version="1">1505023</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2014 Nov 4;111(44):E4779-88</RefSource><PMID Version="1">25331903</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurosci. 2012 Apr 18;32(16):5385-97</RefSource><PMID Version="1">22514303</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Signal. 2009 Jan;21(1):87-94</RefSource><PMID Version="1">18929645</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neuropharmacology. 2005 Nov;49(6):737-49</RefSource><PMID Version="1">16212992</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1992 Nov 15;89(22):10993-7</RefSource><PMID Version="1">1438304</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurosci. 2008 Aug 27;28(35):8821-31</RefSource><PMID Version="1">18753384</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Comp Neurol. 1997 Nov 17;388(2):211-27</RefSource><PMID Version="1">9368838</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1985 Apr;82(7):2173-7</RefSource><PMID Version="1">3872460</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Pharmakopsychiatr Neuropsychopharmakol. 1976 Jan;9(1):2-10</RefSource><PMID Version="1">10584</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurochem. 1998 May;70(5):1973-8</RefSource><PMID Version="1">9572281</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurosci. 1995 Mar;15(3 Pt 1):1714-23</RefSource><PMID Version="1">7534339</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Prog Neurobiol. 2005 Apr;75(6):406-33</RefSource><PMID Version="1">15955613</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mov Disord. 2002 May;17(3):501-8</RefSource><PMID Version="1">12112197</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 1972 Aug 3;287(5):237-42</RefSource><PMID Version="1">4402575</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Med Genet B Neuropsychiatr Genet. 2007 Jun 5;144B(4):541-50</RefSource><PMID Version="1">17440978</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurol Neurosurg Psychiatry. 2008 Apr;79(4):368-76</RefSource><PMID Version="1">18344392</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Psychiatry Res. 2005 Sep 15;136(2-3):247-50</RefSource><PMID Version="1">16129496</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>CRC Crit Rev Biochem. 1987;22(1):1-38</RefSource><PMID Version="1">2888595</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Pharmacol Rev. 2004 Sep;56(3):331-49</RefSource><PMID Version="1">15317907</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Annu Rev Neurosci. 2004;27:509-47</RefSource><PMID Version="1">15217342</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurochem. 2013 Sep;126(5):591-603</RefSource><PMID Version="1">23786406</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Pharmacol. 1978 Jul;14(4):633-43</RefSource><PMID Version="1">98706</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neuron. 2007 Sep 20;55(6):835-58</RefSource><PMID Version="1">17880890</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neuron. 2010 Jan 14;65(1):66-79</RefSource><PMID Version="1">20152114</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Schizophr Bull. 2013 Jul;39(4):848-56</RefSource><PMID Version="1">22532702</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Mol Genet. 2006 Jan 15;15(2):299-305</RefSource><PMID Version="1">16339215</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurosci. 2013 Jan 9;33(2):452-63</RefSource><PMID Version="1">23303926</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Aspects Med. 2013 Apr-Jun;34(2-3):360-72</RefSource><PMID Version="1">23506877</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurosci. 1995 Sep;15(9):6179-88</RefSource><PMID Version="1">7666200</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neurochem Int. 2014 Jul;73:42-8</RefSource><PMID Version="1">24231471</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Neurol. 1997 Apr;41(4):530-9</RefSource><PMID Version="1">9124811</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neuron. 1997 Dec;19(6):1271-83</RefSource><PMID Version="1">9427250</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Neurol. 2001 Jan;49(1):79-89</RefSource><PMID Version="1">11198300</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neurodegeneration. 1995 Sep;4(3):271-81</RefSource><PMID Version="1">8581559</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>ACS Chem Neurosci. 2015 May 20;6(5):790-9</RefSource><PMID Version="1">25746685</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurosci. 2000 Jul 15;20(14):5276-82</RefSource><PMID Version="1">10884311</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Mol Genet. 2006 Oct 15;15(20):3055-62</RefSource><PMID Version="1">16963468</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neurotoxicology. 2012 Mar;33(2):178-88</RefSource><PMID Version="1">22309908</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochem Soc Trans. 2012 Oct;40(5):1111-6</RefSource><PMID Version="1">22988874</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Pharmacol Exp Ther. 2001 Mar;296(3):1023-34</RefSource><PMID Version="1">11181937</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neuron. 2009 Apr 30;62(2):218-29</RefSource><PMID Version="1">19409267</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochemistry. 2002 Apr 9;41(14):4595-602</RefSource><PMID Version="1">11926821</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurosci. 2008 Jul 9;28(28):7040-6</RefSource><PMID Version="1">18614672</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Invest. 2014 Jul;124(7):3107-20</RefSource><PMID Version="1">24911152</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurochem. 2001 Dec;79(5):1033-8</RefSource><PMID Version="1">11739616</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur Neuropsychopharmacol. 2002 Aug;12(4):343-7</RefSource><PMID Version="1">12126874</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 1958 Feb 28;127(3296):471</RefSource><PMID Version="1">13529006</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Brain Res Rev. 2008 Aug;58(2):303-13</RefSource><PMID Version="1">18433875</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurosci. 2007 Jan 31;27(5):981-92</RefSource><PMID Version="1">17267552</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Free Radic Biol Med. 2001 Apr 15;30(8):924-31</RefSource><PMID Version="1">11295535</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Pharmacol Exp Ther. 2013 Jul;346(1):2-10</RefSource><PMID Version="1">23568856</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trends Neurosci. 2004 May;27(5):270-7</RefSource><PMID Version="1">15111009</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurosci. 2001 Jan 1;21(1):305-13</RefSource><PMID Version="1">11150348</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Pharmacol Exp Ther. 1963 Sep;141:285-9</RefSource><PMID Version="1">14064189</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>CNS Neurol Disord Drug Targets. 2006 Feb;5(1):45-56</RefSource><PMID Version="1">16613553</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neurobiol Dis. 2010 Oct;40(1):102-12</RefSource><PMID Version="1">20472063</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neuroscience. 2000;101(1):67-76</RefSource><PMID Version="1">11068137</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Psychiatry. 2011 Nov;16(11):1147-54</RefSource><PMID Version="1">20856250</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Toxicol Lett. 2004 Mar 14;148(1-2):29-40</RefSource><PMID Version="1">15019086</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 2001 Aug;21(16):5321-31</RefSource><PMID Version="1">11463816</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurosci. 2003 Aug 27;23(21):7917-21</RefSource><PMID Version="1">12944522</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Toxicol Sci. 2011 Dec;124(2):225-50</RefSource><PMID Version="1">21914720</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Physiol Paris. 1993;87(3):159-70</RefSource><PMID Version="1">8136785</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>P T. 2008 Dec;33(12):690-4</RefSource><PMID Version="1">19750050</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Med Res Rev. 2011 Jul;31(4):483-519</RefSource><PMID Version="1">20135628</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurosci. 2014 Jun 11;34(24):8210-8</RefSource><PMID Version="1">24920625</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neurobiol Aging. 2011 Oct;32(10):1923.e1-8</RefSource><PMID Version="1">21482443</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Neurosci. 2008 Jul;11(7):780-9</RefSource><PMID Version="1">18568020</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurochem. 1993 Dec;61(6):2314-7</RefSource><PMID Version="1">8245983</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Front Mol Neurosci. 2014 May 27;7:49</RefSource><PMID Version="1">24904275</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Autism Dev Disord. 2004 Jun;34(3):329-39</RefSource><PMID Version="1">15264500</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Brain Res Mol Brain Res. 1999 Nov 10;73(1-2):37-49</RefSource><PMID Version="1">10581396</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neuron. 2003 Sep 11;39(6):889-909</RefSource><PMID Version="1">12971891</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trends Pharmacol Sci. 2008 Jun;29(6):322-9</RefSource><PMID Version="1">18453001</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">DAT</Keyword><Keyword MajorTopicYN="N">Parkinson's disease</Keyword><Keyword MajorTopicYN="N">VMAT2</Keyword><Keyword MajorTopicYN="N">dopamine</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>05</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2016</Year><Month>07</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>08</Month><Day>02</Day></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>01</Month><Day>01</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>8</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>8</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>8</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27520881</ArticleId><ArticleId IdType="doi">10.1111/ejn.13357</ArticleId><ArticleId IdType="pmc">PMC5209277</ArticleId><ArticleId IdType="mid">NIHMS811710</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Canada</li><li>États-Unis</li></country><region><li>Ontario</li></region><settlement><li>Toronto</li></settlement><orgName><li>Université de Toronto</li></orgName></list><tree><country name="États-Unis"><noRegion><name sortKey="Lohr, Kelly M" sort="Lohr, Kelly M" uniqKey="Lohr K" first="Kelly M" last="Lohr">Kelly M. Lohr</name></noRegion><name sortKey="Miller, Gary W" sort="Miller, Gary W" uniqKey="Miller G" first="Gary W" last="Miller">Gary W. Miller</name></country><country name="Canada"><region name="Ontario"><name sortKey="Masoud, Shababa T" sort="Masoud, Shababa T" uniqKey="Masoud S" first="Shababa T" last="Masoud">Shababa T. Masoud</name></region><name sortKey="Salahpour, Ali" sort="Salahpour, Ali" uniqKey="Salahpour A" first="Ali" last="Salahpour">Ali Salahpour</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000055 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 000055 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Canada
|area= ParkinsonCanadaV1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:27520881
|texte= Membrane transporters as mediators of synaptic dopamine dynamics: implications for disease.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:27520881" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a ParkinsonCanadaV1
| This area was generated with Dilib version V0.6.29. |  |